Consolidated Statement of Changes in Capital - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2016 |
Sep. 30, 2016 |
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
$ 740,362
|
| Balance at beginning of year (in shares) |
|
26,632,689
|
| Net income |
$ 13,069
|
$ 25,272
|
| Unrealized gains on available-for-sale securities |
|
13,184
|
| Unrealized losses derivative financial instruments |
|
(2,113)
|
| Currency translation adjustments |
|
(6,516)
|
| Changes in post-retirement benefit obligations |
|
67
|
| Equity compensation - restricted units |
|
281
|
| Equity compensation - subsidiaries |
|
2,407
|
| Purchases of SPLP common units |
|
(7,297)
|
| Subsidiaries' purchases of their common stock |
|
(12,399)
|
| Other, net |
|
(288)
|
| Balance at end of year |
$ 752,960
|
$ 752,960
|
| Balance at end of period (in shares) |
26,152,976
|
26,152,976
|
| Total Partners' Capital |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
$ 558,034
|
| Net income |
|
22,003
|
| Unrealized gains on available-for-sale securities |
|
11,222
|
| Unrealized losses derivative financial instruments |
|
(1,929)
|
| Currency translation adjustments |
|
(5,924)
|
| Changes in post-retirement benefit obligations |
|
81
|
| Equity compensation - restricted units |
|
281
|
| Equity compensation - subsidiaries |
|
1,546
|
| Purchases of SPLP common units |
|
(7,297)
|
| Subsidiaries' purchases of their common stock |
|
13,573
|
| Other, net |
|
(6,020)
|
| Balance at end of year |
$ 585,570
|
$ 585,570
|
| Common Units |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year (in shares) |
|
36,687,913
|
| Equity compensation - restricted units (shares) |
|
23,750
|
| Balance at end of period (in shares) |
36,711,663
|
36,711,663
|
| Treasury Units |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
$ (157,603)
|
| Balance at beginning of year (in shares) |
|
10,055,224
|
| Purchases of SPLP common units |
|
$ (7,297)
|
| Purchases of SPLP common units (shares) |
|
(503,463)
|
| Balance at end of year |
$ (164,900)
|
$ (164,900)
|
| Balance at end of period (in shares) |
10,558,687.000
|
10,558,687.000
|
| Partners' Capital |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
$ 612,302
|
| Net income |
|
22,003
|
| Equity compensation - restricted units |
|
281
|
| Equity compensation - subsidiaries |
|
1,546
|
| Purchases of SPLP common units |
|
(7,297)
|
| Subsidiaries' purchases of their common stock |
|
13,573
|
| Other, net |
|
(6,020)
|
| Balance at end of year |
$ 636,388
|
636,388
|
| Accumulated Other Comprehensive Income |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
(54,268)
|
| Unrealized gains on available-for-sale securities |
|
11,222
|
| Unrealized losses derivative financial instruments |
|
(1,929)
|
| Currency translation adjustments |
|
(5,924)
|
| Changes in post-retirement benefit obligations |
|
81
|
| Balance at end of year |
(50,818)
|
(50,818)
|
| Non-controlling interests in Consolidated Entities |
|
|
| Increase (Decrease) in Partners' Capital [Roll Forward] |
|
|
| Balance at beginning of year |
|
182,328
|
| Net income |
|
3,269
|
| Unrealized gains on available-for-sale securities |
|
1,962
|
| Unrealized losses derivative financial instruments |
|
(184)
|
| Currency translation adjustments |
|
(592)
|
| Changes in post-retirement benefit obligations |
|
(14)
|
| Equity compensation - subsidiaries |
|
861
|
| Subsidiaries' purchases of their common stock |
|
(25,972)
|
| Other, net |
|
5,732
|
| Balance at end of year |
$ 167,390
|
$ 167,390
|